Zhang Yun, Lozano Guillermina
Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Annu Rev Cancer Biol. 2017 Mar;1:185-201. doi: 10.1146/annurev-cancerbio-050216-121926. Epub 2016 Oct 17.
The p53 tumor suppressor has been studied for decades, and still there are many questions left unanswered. In this review, we first describe the current understanding of the wild-type p53 functions that determine cell survival or death, and regulation of the protein, with a particular focus on the negative regulators, the murine double minute family of proteins. We also summarize tissue-, stress-, and age-specific p53 activities and the potential underlying mechanisms. Among all gene alterations identified in human cancers, missense mutations predominate, suggesting an inherent biological advantage. Numerous gain-of-function activities of mutant p53 in different model systems and contexts have been identified. The emerging theme is that mutant p53, which retains a potent transcriptional activation domain, also retains the ability to modify gene transcription, albeit indirectly. Lastly, because mutant p53 stability is necessary for its gain of function, we summarize the mechanisms through which mutant p53 is specifically stabilized. A deeper understanding of the multiple pathways that impinge upon wild-type and mutant p53 activities and how these, in turn, regulate cell behavior will help identify vulnerabilities and therapeutic opportunities.
p53肿瘤抑制蛋白已被研究了数十年,但仍有许多问题悬而未决。在本综述中,我们首先描述对野生型p53决定细胞存活或死亡功能以及该蛋白调控的当前理解,特别关注负调控因子——小鼠双微体蛋白家族。我们还总结了组织、应激和年龄特异性的p53活性及其潜在机制。在人类癌症中鉴定出的所有基因改变中,错义突变占主导,这表明其具有内在生物学优势。已在不同模型系统和背景中鉴定出突变型p53的多种功能获得性活性。新出现的观点是,保留有效转录激活结构域的突变型p53也保留了改变基因转录的能力,尽管是间接的。最后,由于突变型p53的稳定性是其功能获得所必需的,我们总结了突变型p53被特异性稳定的机制。深入了解影响野生型和突变型p53活性的多种途径以及这些途径如何反过来调节细胞行为,将有助于确定薄弱环节和治疗机会。